Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study
- Alten, Rieke
- Nüßlein, Hubert
- GALEAZZI, MAURO
- Lorenz, Hanns Martin
- Nurmohamed, Michael T
- Bensen, William G
- Burmester, Gerd R
- Peter, Hans Hartmut
- Pavelka, Karel
- Chartier, Mélanie
- Poncet, Coralie
- Rauch, Christiane
- Elbez, Yedid
- Le Bars, Manuela
Publication date
January 2016
DOI Publisher
BMJ ISSN
2056-5933 Citation count (estimate)
2Abstract
Prolonged glucocorticoid use may increase the risk of adverse safety outcomes, including cardiovascular events. The European League Against Rheumatism and the Canadian Rheumatology Association advise tapering glucocorticoid dose as rapidly as clinically feasible. There is a paucity of published data on RA that adequately describe concomitant treatment patterns
Add to ORKG